A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial)
Clinical trial NCT04865770 · COMPLETED
Trial details
- NCT number
- NCT04865770
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-28
- Primary completion
- 2024-11-21
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.